Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors

  • Fischer M
  • Schneeweiss S
  • Avorn J
  • et al.
109Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Over the past five years, selective cyclooxygenase-2 inhibitors (coxibs) have accounted for a growing proportion of prescriptions for nonsteroidal antiinflammatory drugs (NSAIDs). To control these expenses, many state Medicaid programs have implemented prior-authorization requirements before coxibs can be prescribed. We evaluated the effect of such programs on the use of coxibs by Medicaid beneficiaries.METHODS: We surveyed state Medicaid agencies to determine whether prescription of coxibs required prior authorization and, if so, the criteria for authorization. For each program, we compared these criteria with evidence-based recommendations for prescribing of coxibs. Using data for all filled prescriptions in 50 state Medicaid programs from 1999 through the end of 2003, we calculated the proportion of defined daily doses of NSAIDs accounted for by coxibs. Time-series analyses were used to measure the changes in prescription patterns after the implementation of each prior-authorization program.RESULTS: By 2001, coxibs accounted for half of all NSAID doses covered by Medicaid. This proportion varied widely according to the state in 2003, from a low of 11 percent to a high of 70 percent of all NSAID doses. Twenty-two states implemented prior-authorization programs for coxibs during the study period. Overall, the implementation of such programs reduced the proportion of NSAID doses made up by coxibs by 15.0 percent (95 percent confidence interval, 10.9 to 19.2 percent), corresponding to a decrease of 10.28 dollars (95 percent confidence interval, 7.56 dollars to 13.00 dollars) in spending per NSAID prescription. The effect of such programs was not influenced by the degree to which a prior-authorization program incorporated evidence-based prescribing recommendations.CONCLUSIONS: The use of coxibs and spending on NSAIDs varies widely by state and declined substantially after the implementation of prior-authorization programs. Determining whether these reductions are clinically appropriate will have important implications for the development of rational drug-reimbursement policies.

References Powered by Scopus

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis

3824Citations
N/AReaders
Get full text

Segmented regression analysis of interrupted time series studies in medication use research

2487Citations
N/AReaders
Get full text

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update

2042Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prescription drug cost sharing: Associations with medication and medical utilization and spending and health

689Citations
N/AReaders
Get full text

Trends and geographic variation of opiate medication use in state medicaid fee-for-service programs, 1996 to 2002

131Citations
N/AReaders
Get full text

National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs

127Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fischer, M. A., Schneeweiss, S., Avorn, J., & Solomon, D. H. (2004). Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors. New England Journal of Medicine, 351(21), 2187–2194. https://doi.org/10.1056/nejmsa042770

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

62%

Professor / Associate Prof. 7

18%

Researcher 7

18%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 23

57%

Economics, Econometrics and Finance 7

18%

Social Sciences 6

15%

Pharmacology, Toxicology and Pharmaceut... 4

10%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free